GENEVA, Sept. 24 -- REJDAK, Konrad filed a patent application (EP2026/057814) for “USE OF CLADRIBINE FOR TREATING CHRONIC IMMUNE-MEDIATED NEUROPATHIES (CIMN)”. With publication no. WO/2026/195809, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/7076
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....